Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial (2023)
- Authors:
- USP affiliated authors: OLIVEIRA, CLAUDIA PINTO MARQUES SOUZA DE - FM ; LOPES, MARTA HELOISA - FM ; CARRILHO, FLAIR JOSÉ - FM
- Unidade: FM
- DOI: 10.1016/j.aohep.2022.100891
- Subjects: CIRROSE HEPÁTICA; HEPATITE CRÔNICA; VACINAS VIRAIS; VACINAÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Título: Annals of hepatology
- ISSN: 1665-2681
- Volume/Número/Paginação/Ano: v. 28, n. 2, article ID 100891, 6p, 2023
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
MEDEIROS, Roseane P et al. Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial. Annals of hepatology, v. 28, n. 2, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52954. Acesso em: 04 ago. 2025. -
APA
Medeiros, R. P., Terrault, N. A., Mazo, D. F., Oliveira, C. P. M. S. de, Dodge, J., Zitelli, P. M., et al. (2023). Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial. Annals of hepatology, 28( 2). doi:10.1016/j.aohep.2022.100891 -
NLM
Medeiros RP, Terrault NA, Mazo DF, Oliveira CPMS de, Dodge J, Zitelli PM, Lopes MH, Carrilho FJ, Pessoa MG. Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial [Internet]. Annals of hepatology. 2023 ; 28( 2):[citado 2025 ago. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52954 -
Vancouver
Medeiros RP, Terrault NA, Mazo DF, Oliveira CPMS de, Dodge J, Zitelli PM, Lopes MH, Carrilho FJ, Pessoa MG. Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial [Internet]. Annals of hepatology. 2023 ; 28( 2):[citado 2025 ago. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52954 - Microsomal triglyceride transfer protein (MTP) 493 G/T polymorphism is associated with insulin resistance in chronic hepatitis (CHC) genotype infection
- Genetic ancestry analysis in non-alcoholic fatty liver disease patients from Brazil and Portugal
- S-Nitroso-N-acetylcysteine induces de-differentiation of activated hepatic stellate cells and promotes antifibrotic effects in vitro
- Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and high plasma homocysteine in chronic hepatitis C (CHC) infected patients from the Northeast of Brazil
- Yo Jyo Hen Shi Ko (YHK) Modulates the Expression of Proteins Involved in de novo Lipogenesis and Lipid Exportation in Experimental Nonalcoholic Steatohepatitis (NASH)
- Clinical patterns of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) ]Editorial]: a multicenter prospective study
- Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
- Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population
- Impact of current diet at the risk of non-alcoholic fatty liver disease (NAFLD)
- The Antibody response to hepatitis B virus vaccination is not influenced by the hepatitis C virus viral load in patients with chronic hepatitis C
Informações sobre o DOI: 10.1016/j.aohep.2022.100891 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
